Smith-Lemli-Opitz syndrome/RSH (SLOS) is
Introduction
The Smith-Lemli-Opitz/RSH syndrome (SLOS) [MIM 270400] 1 is an autosomal recessive disorder with an estimated frequency of 1:15.000 to 1:40.000 in European populations. [2] [3] [4] The syndrome is reportedly common in the Czech Republic and Slovakia and is rare or absent in nonCaucasian populations. SLOS is the prototype of a severe human malformation syndrome which is caused by an inborn error of metabolism. [5] [6] [7] The syndrome is characterised by a variable combination of malformations, dysmorphic signs and mental retardation including growth retardation, microcephaly, genital anomalies in males, postaxial polydactyly and 2/3 syndactyly of toes. Severity ranges from intrauterine lethality to mild dysmorphism and moderate mental impairment. 2, 8, 9 Diagnosis may be difficult at both ends of the clinical spectrum. 10, 11 A breakthrough in the knowledge of the etiology and pathogenesis of the SLOS was the demonstration by Irons, Tint and colleagues that SLOS is caused by an error in the biosynthesis of cholesterol. 12, 13 The last step in the biosynthesis of cholesterol is the conversion of 7-dehydrocholesterol (7DHC) to cholesterol which is catalysed by the enzyme ∆7-sterol reductase (DHCR7, EC13121) in the endoplasmatic reticulum. This step is defective in patients with SLOS 13 resulting in low cholesterol and accumulation of the precursors 7DHC, 8DHC and others in plasma and cells. This allows for the biochemical diagnosis of the syndrome. 9 Recently the gene coding for DHCR7 has been cloned 14 and mutations in the gene were identified in all patients with biochemically confirmed SLOS. [15] [16] [17] [18] [19] [20] The mutational spectrum in the DHCR7 gene from a large group of patients with SLOS has been determined and a genotype-phenotype correlation has been established. 18 Altogether over 40 DHCR7 mutations have been described in SLOS patients some of which were frequent. The three most common mutations identified in patients of European and EuropeanAmerican ancestry included two null mutations, ie IVS8-1G > C and W151X, which in homozygotes or compounds are associated with the most severe phenotypes. 18, 21 In order to elucidate the origin and age of SLOS-causing mutations we have started to analyse DHCR7 gene mutations in SLOS patients from different European countries. Here we report the mutational spectra of SLOS mutations in three European populations and demonstrate significant differences in the frequency spectra of SLOS mutations across these populations. The frequency distributions and haplotype analysis suggest multiple origins of SLOS mutations in Europe.
Patients and methods

Patients
The study population included 59 unrelated patients with SLOS. They were recruited from various clinical genetic centres in Austria (n = 3), Germany (n = 19), Great Britain (n = 22) and Poland (n = 15). For the frequency analysis the Austrian and German patients were combined. All 59 patients had characteristic clinical features of SLOS and for 56 patients it was possible to confirm the clinical diagnosis by biochemical analysis of sterols (quantification by gas chromatography/mass spectrometry). 22 A detailed clinical and biochemical characterisation of 12 of the Polish SLOS patients has been published. 23 Eight of the British patients were recruited in the USA (Dr R Kelley). For these patients a British parental and grand-parental origin was known. Sixteen of the Austrian/German and 12 of the British patients were from the large collection of SLOS patients reported previously. 18 For haplotype analysis also patients from a previous study were considered.
18
Mutation and haplotype analysis Amplification of DNA, SSCP, DGGE and sequencing were performed exactly as described 18 using the primers and experimental condition described therein. 
Results
Using a combination of SSCP, DGGE and direct sequencing 18 we analysed all exons including exon/intron boundaries of the DHCR7 gene from 22 British, 22 German and Austrian and 15 Polish patients with SLOS for mutations. Altogether 35 different mutations were present in the total group. Twenty-six of these have been previously identified by us 15, 18 and others. 16, 17, 19, [24] [25] [26] Six of the mutations have not been described before (T154R, M270V, G309S, R443H, I178N, R242H). No mutation was found on four out of 118 SLOS chromosomes from four patients (96.6% mutation-detection rate). The spectrum of mutations was most heterogeneous in the British SLOS patients and more homogeneous in the Polish patients. The most frequent mutations in the total same were IVS8-1G > C (0.21) W151X (0.16), and V326L (0.14).
Spectrum of DHCR7 mutations in Polish SLOS patients
The mutational spectrum in the Polish patients was distinctly different from the ones in British and German/Austrians (Table 1) . Altogether 11 different mutations were identified. Among the Polish SLOS patients three mutations (W151X, V326L, R352W) were present on > 0.7 of SLOS chromosomes. These mutations were also present in the other populations Mutations not previously identified. TM=transmembrane, CT=C-terminal, 0=null mutation. 
Frequency gradients of SLOS mutations in Europe
Spectrum of DHCR7 mutations in British SLOS patients
Twenty-one different mutations and one unknown were present in the British SLOS patients ( Table 2 ). The splice site mutation IVS8-1G > C was the most frequent and accounted for one third (0.34) of British SLOS chromosomes. This mutation has also been identified as the most frequent in a mixed American/European sample of SLOS patients 18 and in an American SLOS population. 19 The relative frequency of the IVS8-1G > C mutation was even higher (0.46) when only SLOS patients born and identified in Great Britain were considered (n = 14). None of the other mutations had a frequency of > 0.1. The mutation R404C had a frequency of 0.091. The third most frequent mutation (0.068) in the British T93M was recently identified as the most frequent mutation among Italian SLOS patients. 24 All other British SLOS mutations were rare and represented by only one or two alleles.
Spectrum of DHCR7 mutations in German and Austrian SLOS patients
Sixteen different mutations were identified on 44 chromosomes (Table 3 ). In three of the biochemically analysed SLOS patients no mutation could be identified on one chromosome. Three mutations (IVS8-1G > C, V326L and W151X) were frequent. For all three mutations frequencies were intermediate between the respective British and Polish frequencies.
Haplotype analysis
We used eight single nucleotide polymorphisms in the coding sequence of the DHCR7 gene to construct haplotypes: 189A > G; 207C > T; 231C > T; 438C > T, 969G > A, 1158C > T, 1272T > C, 1350C > T (Table 4A ). In 24 patients haplotype analysis was performed and information was obtained for 47 mutant DHCR7 alleles. These represented 14 different mutations. Altogether we observed nine different haplotypes; 28 mutant DHCR7 chromosomes representing nine different mutations were all characterised by the same haplotype, whereas 19 mutant DHCR7 alleles (eight different mutations) occurred on eight different haplotypes (Table 4B) .
The six common mutations (IVS8-1G > C, R404C, T93M, W151X, V326L, R352W) occurred on seven different haplotypes. Three of the frequent mutations (R404C, T93M, R352W) involve CpGs. Each of these mutations occurred on at least two different haplotypes which differed at more than one of the polymorphic sites (eg R352W occurred on haplotypes A and I). Hence the high frequency of these mutations is most likely explained by recurrent mutations.
In contrast 13 IVS8-1G > C and 5 V326L chromosomes were all characterised by the same DHCR7 haplotype. Only one IVS8-1G > C mutation was present on a different haplotype. This mutation was present in cis with a T93M Mutations not previously identified. TM=transmembrane, CT=C-terminal, 0=null mutation, 4L=4th cytoplasmic loop. Mutation not previously identified. TM=transmembrane, CT=C-terminal, 0=null mutation, 4L=4th cytoplasmic loop.
Frequency gradients of SLOS mutations in Europe
One of the other T93M alleles was also characterised by this haplotype. Hence the double mutant likely arose by recombination. Together the haplotype data suggest that IVS8-1G > C and V329L are founder mutations.
Discussion
With the exception of two small studies, one from the Netherlands involving three patients 17 27 As noted previously 18 it is intriguing that two of the most common SLOS-causing mutations are null mutations. We do not know the origin or age of any of these and their exact population frequencies are at present unknown. We did not observe a single consanguineous marriage among the 59 SLOS families which might indicate that DHCR7 mutations are more common than suggested by the reported incidence of SLOS. Only for the common IVS8-1G > C mutation limited population data are available. This mutation was observed once among 90 normal adult Caucasian Americans but not among Africans, Chinese, Japanese, and Finns. 19 The latter is compatible with the virtual absence of the SLOS from Finland (H. Kääriänen, 1999, personal communication). The frequency distributions observed here in SLOS patients can be explained by different scenarios. One is that there is a high frequency of recurrent mutations at the DHCR7 locus which has created different random frequency spectra in European populations. However, this seems unlikely in view of the presence of frequency gradients and a very high relative frequency of some mutations (eg IVS8-1G > C). Further, none of the frequent null mutations (IVS8-1G > C and W151X) involve CpGs, whereas some other frequent mutations ie T93M, R352W, and R404C are at CpGs. Our limited haplotype analysis is consistent with this interpretation. All IVS8-1G > C alleles (n = 13) and all V326L alleles (n = 5) shared the same haplotype. Almost two-thirds of all DHCR7 mutations occurred on this haplotype. But we do not yet know the frequency of this common SLOS haplotype in the general population. Some of the mutations involving CpGs (R352W, T93M, and R404C) occurred on chromosomes with different DHCR7 haplotypes. Hence there is evidence also from haplotype analysis for both recurrent mutations and founder effects. This situation is still unclear for the W151X mutation. This mutation, despite the clear frequency gradient, occurred on three different haplotypes (Table 4B ). These differed only at single nucleotide positions and therefore may all be derived from the same Table 4 A DHCR7 haplotypes in 24 SLOS patients
B Haplotype distribution of DHCR7 mutations in 24 SLOS patients
Mutation Haplotype
A (1) a number of alleles in parenthesis.
b one E allele carries both mutations: IVS8-1G>C and T93M (see text). The presence of opposite gradients from west to east and east to west of several DHCR7 mutations is not easily explained by the demic diffusion model of the peopling of Europe by neolithic farmers, which is believed to explain some of the gene frequency gradients in Europe (first principle component). 28, 29 Rather, a more complex situation seems to exist. Among the populations studied the frequency of the IVS8-1G > C mutation is highest in Britain. This mutation is obviously rare in South and East Europe. It was not observed among 18 SLOS alleles from southern Italy 24 and is rare in Poland (see Table 1 ). Its frequency increased towards the northwest. This mutation may therefore characterise northern European populations. The high frequency and distribution of the IVS8-1G > C mutation could reflect migrations and/or replacement of ancient European populations carrying this mutation, as has been suggested for the ∆F508 mutation causing cystic fibrosis. 30 In support of the notion that the IVS8-1G > C is old is our previous observation that two SLOS chromosomes carried two different mutations. Both double mutant alleles involved the IVS8-1G > C site together with either R352Q (which is rare) or T93M which is frequent in Italy. Less likely, such double mutation alleles might have arisen by intragenic recombination. It is however intriguing that the parents of one of the patients (D111 in Witsch-Baumgartner 18 ) with a double mutant allele (genotype IVS8-1G > C/T93M/IVS8-1G > C) had Irish/English ancestors on the maternal side and Italian ancestors on the paternal side. Haplotype analysis of this patient together with the haplotype distribution of IVS8-1G > C and T93M mutations is indeed consistent with a recombination event (Table 4B) . Notably the frequency gradient of the W151X mutation is in a direction opposite to the gradient of the IVS8-1G > C mutation. A similar gradient has been described for the R408W mutation in the PHA gene on haplotype 2 chromosomes from patients with phenylketonuria. 27 This gradient has been related to an east-west cline in polymorphic marker frequencies believed to reflect the so-called Kurgan expansion of pastoral nomads speaking Indo-European languages which occurred between 4300 and 3000 BC. There have been further extensive migrations in Europe over the last 2000 years however, and even quite recently, eg there was a large immigration from Poland to the coal-mining areas of the Ruhr district in Germany in the nineteenth century. Such migrations may well explain the frequency gradient of the 'Polish' W151X mutation. Hence the distribution pattern of DHCR7 mutations in Europe as it starts to emerge from this study might be a reflection of ancient and modern migrations in Europe. In a recent study De Brasi et al 24 reported that T93M is the most frequent DHCR7 mutation in Italian SLOS patients. Thus the pattern of SLOS mutations in Caucasians may be more complex than indicated by the present data. The R404C mutation which is the second most frequent in the British SLOS patients was previously identified in homozygous form in related families of French ancestry from a Louisiana parish in the USA and considered a French founder mutation. 18 It will be interesting to see whether and in what frequency this mutation is present on French SLOS chromosomes and whether it spread from France to Britain with, for example, the Norman invasion. T93M is also among the three most frequent mutations in Great Britain but was absent in the German/Austrian and Polish samples. Whether this reflects ancient migrations (eg the Roman occupation of the southern parts of Great Britain) or still another cline needs to be clarified by analysis of further populations (such as France) in combination with haplotype analysis. A more detailed analysis of the frequencies and haplotypes of the common mutations in various European populations may not only shed more light on their origins and ages but also may give new insights into the genetic structure and migrations of European populations. It might also provide clues towards possible selective forces explaining the high frequency of DHCR7 mutations in Europeans and their absence in most non-Europeans.
Finally our results have also practical implication since they provide strategies for mutation detection in different European regions.
